FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:2621-2622 June 15, 2006 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: Lymphangioleiomyomatosis, a rare lung disease typically affecting women of reproductive age, is characterized by an abnormal proliferation of smooth-muscle cells and the progressive loss of pulmonary function due to destruction of lung parenchyma.¹ Long-term survival is rare; in patients with lymphangioleiomyomatosis, respiratory failure often develops within 10 years after diagnosis. Currently, there is no standard-of-care therapy for this disease, although limited success has been reported with hormone therapy or lung transplantation.

The destruction of lung parenchyma has been attributed to an environment conducive to proteolysis resulting from increased expression and activity of matrix metalloproteinases (MMPs). MMP-2, in . . . [Full Text of this Article]

This article has been cited by other articles:

• El-Chemaly, S., Taveira-DaSilva, A., Stylianou, M. P., Moss, J. (2009). Statins in lymphangioleiomyomatosis: a word of caution. Eur Respir J 34: 513-514 [Full Text]  
• Paul, S., Su, S., Edenfield, H., Kwiatkowski, D. J., Bueno, R. (2009). Treatment of refractory lymphangioleiomyomatosis-associated chylous effusion with a pleuroperitoneal window and omental flap.. J. Thorac. Cardiovasc. Surg. 138: 497-498 [Full Text]  
• Chen, F., Omasa, M., Kondo, N., Fujinaga, T., Shoji, T., Sakai, H., Bando, T. (2009). Sirolimus Treatment for Recurrent Lymphangioleiomyomatosis After Lung Transplantation. Ann. Thorac. Surg. 87: e6-e7 [Abstract] [Full Text]  
• West, J., Harral, J., Lane, K., Deng, Y., Ickes, B., Crona, D., Albu, S., Stewart, D., Fagan, K. (2008). Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L744-L755 [Abstract] [Full Text]  
• Fainaru, O., Adini, I., Benny, O., Bazinet, L., Pravda, E., D'Amato, R., Folkman, J. (2008). Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J. 22: 3728-3735 [Abstract] [Full Text]  
• Pories, S. E., Zurakowski, D., Roy, R., Lamb, C. C., Raza, S., Exarhopoulos, A., Scheib, R. G., Schumer, S., Lenahan, C., Borges, V., Louis, G. W., Anand, A., Isakovich, N., Hirshfield-Bartek, J., Wewer, U., Lotz, M. M., Moses, M. A. (2008). Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment. Cancer Epidemiol. Biomarkers Prev. 17: 1034-1042 [Abstract] [Full Text]  
• McCormack, F. X. (2008). Lymphangioleiomyomatosis*: A Clinical Update. Chest 133: 507-516 [Abstract] [Full Text]  
• Juvet, S. C., McCormack, F. X., Kwiatkowski, D. J., Downey, G. P. (2007). Molecular Pathogenesis of Lymphangioleiomyomatosis: Lessons Learned from Orphans. Am. J. Respir. Cell Mol. Bio. 36: 398-408 [Abstract] [Full Text]